Answers are grounded in this paper and cite their sources.
Epithelial–mesenchymal transition (EMT) is a molecular process of cellular plasticity that dynamically changes in response to diverse stimuli. EMT contributes to cancer progression by promoting phenotypic changes associated with metastasis. The mechanisms underlying EMT are complex and involve several regulatory factors and signaling pathways, including estrogens and their receptors, which play a key role in the evolution and progression of various neoplasms. However, the interplay between estrogen signaling and EMT is intricate, cell context-dependent, and varies with tumor type and the signaling pathways involved. The role of estrogens in EMT is essential for elucidating the molecular mechanisms underlying cancer progression and may contribute to the identification of biomarkers and the development of therapeutic strategies that account for the heterogeneity of estrogen-mediated EMT across different cancers.
No takes yet. Share an insight, caveat, or question.
Peña‐Gutiérrez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: